Latest News
Promised land
Blended solutions gain momentum and reveal untapped potential Blended solutions gain momentum and reveal untapped potential
eXmoor and Anthony Nolan partner to streamline cell therapy development
Collaboration offers end-to-end support from donor sourcing to manufacturing Collaboration offers end-to-end support from donor sourcing to manufactur...
Polpharma Biologics and MS Pharma partner to expand biosimilar access
Deal covers biosimilars for gastroenterology, neurology and dermatology Deal covers biosimilars for gastroenterology, neurology and dermatology
Lilly receives UK approval for pirtobrutinib in relapsed blood cancers
MHRA grants conditional authorisation for treatment targeting mantle cell lymphoma MHRA grants conditional authorisation for treatment targeting mantl...
FDA approves LEQEMBI IQLIK for maintenance dosing in early Alzheimer’s disease
New subcutaneous autoinjector offers at-home treatment option for patients New subcutaneous autoinjector offers at-home treatment option for patients
Coya Therapeutics to progress trial of ALS treatment upon FDA approval
The US Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application from Coya Therapeutics for COYA 302, enabling the...
Akiram advances trial of targeted radiotherapy for solid tumours
Swedish biotech company Akiram Therapeutics has announced significant progress in its first clinical trial of AKIR001, a radiopharmaceutical intended...
Johnny Cheng appointed as interim CEO of HUTCHMED
HUTCHMED has announced that Weiguo Su, CEO of the company, will take a leave of absence from his duties due to health reasons. As a result, the board...
Encare’s ERAS system gains Mayo Clinic qualification, strengthening global reach
Encare’s ERAS Interactive Audit System (EIAS) has earned qualification on the Mayo Clinic Platform_Solutions Studio – a distinction rarely awarded to...
Anne White to retire as head of Lilly Neuroscience after three decades at company
Eli Lilly and Company has announced that Anne White, executive vice president and president of Lilly Neuroscience, will retire at the end of 2025 afte...
Promised land
eXmoor and Anthony Nolan partner to streamline cell therapy development
Polpharma Biologics and MS Pharma partner to expand biosimilar access
Lilly receives UK approval for pirtobrutinib in relapsed blood cancers
FDA approves LEQEMBI IQLIK for maintenance dosing in early Alzheimer’s disease
Coya Therapeutics to progress trial of ALS treatment upon FDA approval
Akiram advances trial of targeted radiotherapy for solid tumours
Johnny Cheng appointed as interim CEO of HUTCHMED
Encare’s ERAS system gains Mayo Clinic qualification, strengthening global reach
Anne White to retire as head of Lilly Neuroscience after three decades at company
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago